XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In- Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive (Loss) Income
Total Common Equity
Noncontrolling Interests in Subsidiaries
Balance at Oct. 31, 2021 $ 31,951 $ 71 $ 25,556 $ 12,963 $ (2,017) $ 36,573 $ (4,622)
Balance (in Shares) at Oct. 31, 2021   7,036          
Stock based compensation expense 1,192 1,192 1,192
Vested share units granted to directors 1,861 $ 1 1,860 1,861
Vested share units granted to directors (in Shares)   100          
Stock options exercised 2,028 $ 1 2,027 2,028
Stock options exercised (in Shares)   185          
Distributions to noncontrolling interests in subsidiaries (20,091) (20,091)
Net income (loss) 69,244 45,992 45,992 23,252
Dividends declared (65,163) (65,163) (65,163)
Net unrealized loss on interest rate swap contracts 3,717 3,426 3,426 291
Balance at Oct. 31, 2022 24,739 $ 73 30,635 (6,208) 1,409 25,909 (1,170)
Balance (in Shares) at Oct. 31, 2022   7,321          
Stock based compensation expense 11 11 11
Stock awards granted to directors 140 140 140
Stock awards granted to directors (in Shares)   9          
Vested share units granted to directors 26 26 26
Vested share units granted to directors (in Shares)   2          
Stock options exercised 1,263 $ 1 1,262 1,263
Stock options exercised (in Shares)   118          
Distributions to noncontrolling interests in subsidiaries (3,535) (3,535)
Net income (loss) (575) 760 760 (1,335)
Dividends declared (3,520) (3,520) (3,520)
Net unrealized loss on interest rate swap contracts (73) (73) (73)
Balance at Oct. 31, 2023 18,476 $ 74 32,074 (8,968) 1,336 24,516 (6,040)
Balance (in Shares) at Oct. 31, 2023   7,450          
Stock based compensation expense 1 1 1
Stock awards granted to directors 141 $ 1 140 141
Stock awards granted to directors (in Shares)   8          
Net unrealized loss on investment in U.S. treasury securities available-for-sale (12) (12) (12)
Stock options exercised 38 38 38
Stock options exercised (in Shares)   5          
Distributions to noncontrolling interests in subsidiaries (2,220) (2,220)
Net income (loss) 16,933 15,852 15,852 1,081
Dividends declared (6,343) (6,343) (6,343)
Net unrealized loss on interest rate swap contracts (830) (830) (830)
Balance at Oct. 31, 2024 $ 26,184 $ 75 $ 32,253 $ 541 $ 494 $ 33,363 $ (7,179)
Balance (in Shares) at Oct. 31, 2024   7,463